Editas Medicine Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-153.22	-220.43	-192.5	-115.98	-133.75	-109.95	-120.32	-97.23	-73.29	-13.99
Depreciation & Amortization	6.06	6.34	5.05	3.96	2.83	3.25	2.68	1.2	0.47	0.16
Share-Based Compensation	19.8	29.29	43.4	23.16	27.24	26.6	23.36	16.88	3.51	0.06
Other Operating Activities	-4.82	7.45	-19.75	-90.98	63	34.4	84.86	28.85	63.47	4.82
Operating Cash Flow	-132.18	-177.35	-163.8	-179.84	-40.67	-45.71	-9.42	-50.25	-5.44	-8.66
Capital Expenditures	-4.72	-4.1	-7.98	-7.15	-6.07	-4.72	-2.04	-3.47	-1.43	-1.22
Change in Investments	0.99	118.17	-46.49	-133.37	18.32	-48.37	-181.77	0	0	0
Investing Cash Flow	-3.73	114.07	-54.47	-140.52	12.25	-53.09	-183.81	-3.47	-1.43	-1.22
Share Issuance / Repurchase	118.04	1.28	282.11	224.12	131.82	87.8	155.9	97.72	-1.74	0.04
Debt Issued / Paid	0	0	0	0	0	-0.86	-1.36	-0.56	-0.5	0.46
Other Financing Activities	-	-	-	-	-	-	-	-	141.63	17.98
Financing Cash Flow	118.04	1.28	282.11	224.12	131.82	86.94	154.53	97.16	139.39	18.48
Net Cash Flow	-17.87	-62	63.84	-96.24	103.41	-11.85	-38.69	43.44	132.52	8.61
Free Cash Flow	-136.9	-181.45	-171.78	-186.99	-46.73	-50.42	-11.46	-53.72	-6.87	-9.87
Free Cash Flow Margin	-175.23%	-920.50%	-672.49%	-206.09%	-227.63%	-157.89%	-83.49%	-887.48%	-421.98%	-
Free Cash Flow Per Share	-1.80	-2.64	-2.54	-3.19	-0.94	-1.07	-0.28	-1.67	-2.68	-8.79

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).